Consumer Staples

The Calmer Co International Limited (CCO)

The Calmer Co International Limited develops and sells natural products for stress relief, relaxation, and sleep, primarily derived from Noble Kava. The company operates a vertically integrated supply chain from its nucleus farm in Fiji and markets its products, including capsules, powders, and the 'Leilo' ready-to-drink beverage, in Australia, the USA, and online.

Market Cap

A$9M

Shares on Issue

N/A

Company WebsiteAI coverage updated hourlyData from ASX filings

Price Chart

Loading chart…

AI Analysis

As a speculative micro-cap with a market capitalisation of A$14M, The Calmer Co's current position is focused on scaling revenue and achieving profitability. Recent performance is heavily tied to its US market expansion with the Leilo functional beverage and growing its direct-to-consumer e-commerce channels. The company is pre-profit, and key metrics for investors are quarterly cash receipts (from Appendix 4C reports), cash burn rate, and progress on securing retail distribution, as these indicate its path to self-sustainability.

The company's growth outlook is contingent on successfully penetrating the large and competitive US functional beverage market. Upcoming catalysts include securing new distribution agreements with major US retailers, positive sales data from existing stockists, and potential product line extensions. CCO's strategic direction involves significant marketing investment to build brand awareness for Fiji Kava and Leilo, leveraging the consumer trend towards natural wellness and non-alcoholic relaxation alternatives. Future capital raisings are likely required to fund this aggressive growth strategy.

Bull Case

  • Significant growth potential in the US market through the expansion of its Leilo ready-to-drink Kava beverage into major retail chains.
  • Vertically integrated 'farm-to-shelf' supply chain in Fiji provides control over quality, traceability, and sourcing of its key Kava ingredient.
  • Positioned to benefit from the growing consumer wellness trend and demand for natural, non-alcoholic alternatives to manage stress and anxiety.

Bear Case

  • High cash burn rate and reliance on capital markets for funding, posing a risk of shareholder dilution through future capital raisings.
  • Intense competition in the functional beverage and wellness product sectors from larger, better-capitalised companies.
  • Execution risk associated with scaling a consumer brand in the highly competitive and fragmented US retail landscape.

Market Sentiment

🟢 BullishScore: +1.00
BearishBullish
2 bullish0 bearish0 neutral

Based on 2 social posts

Recent mentions

twitter2026-02-14

Cantor Fitzgerald reaffirms buy recommendation and price target for Cameco

twitter2026-02-14

The poster is optimistic about the stocks' performance

Recent Announcements

Quarterly Activities Report

Highlights production updates, capital allocation priorities, and FY guidance commentary.

Investor Presentation

Strategic outlook with market positioning and growth pipeline.

FAQs

What does CCO do?

The Calmer Co International (CCO) specialises in natural stress relief and relaxation products derived from Noble Kava. They operate a vertically integrated supply chain from their farm in Fiji and sell products like powders, capsules, and a ready-to-drink beverage under brands including Fiji Kava and Leilo, primarily in Australia and the USA.

Is CCO a good investment?

CCO is a high-risk, high-potential-reward investment. The opportunity lies in its potential to capture a share of the growing global wellness and functional beverage market. However, as a speculative micro-cap company, it faces significant risks including high cash burn, intense competition, and the need for future capital which could dilute shareholders.

What drives CCO's share price?

CCO's share price is primarily driven by news flow related to its US expansion, such as securing new retail distribution agreements. Other key drivers include quarterly sales figures, cash flow reports (Appendix 4C), successful capital raises, and broader market sentiment towards the wellness and consumer staples sectors.

Key Metrics

Share PriceA$0.00
1Y Performance0.0%
Market CapA$9M
Shares on IssueN/A
SectorConsumer Staples
IPO Date20/12/2018

Related Stocks

Consumer Staples

A2MThe A2 Milk Company Limited

A$9.58

17.1% 1Y

The A2 Milk Company Limited operates in the consumer staples sector, focusing on milk and related products. It develops, markets, and distributes A2 dairy products, primarily in New Zealand, Australia, China, and the United States. Key products include A2 Ultra millions, A2 Organic milk, and infant formula.

Market cap A$6.9BView analysis

Consumer Staples

AACAustralian Agricultural Company Limited.

A$1.32

-7.7% 1Y

Australian Agricultural Company (AAC) is one of Australia's largest beef producers and landholders, primarily focused on breeding, raising, and marketing Wagyu and other premium beef brands. Operating vast cattle stations across Northern Australia, the company manages the full supply chain from pasture to plate, including properties, cattle, and feedlots. Its key products include high-quality Wagyu beef sold globally under brands like Master Kobe and Wylarah.

Market cap A$796MView analysis

Consumer Staples

AAPAustralian Agricultural Projects Limited

A$0.05

19.5% 1Y

Australian Agricultural Projects Ltd is an agribusiness company focused on the management and operation of olive groves in Victoria, Australia. The company's primary activities involve the harvesting and processing of olives to produce premium extra virgin olive oil for both domestic and international markets. Additionally, AAP provides horticultural management and consulting services for its own and third-party agricultural assets.

Market cap A$18MView analysis